Annual Retained Earnings
-$694.87 M
-$60.64 M-9.56%
December 31, 2023
Summary
- As of February 8, 2025, FBIO annual retained earnings is -$694.87 million, with the most recent change of -$60.64 million (-9.56%) on December 31, 2023.
- During the last 3 years, FBIO annual retained earnings has fallen by -$212.11 million (-43.94%).
- FBIO annual retained earnings is now -1128.25% below its all-time high of -$56.57 million, reached on December 31, 2011.
Performance
FBIO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$734.10 M
-$12.87 M-1.78%
September 30, 2024
Summary
- As of February 8, 2025, FBIO quarterly retained earnings is -$734.10 million, with the most recent change of -$12.87 million (-1.78%) on September 30, 2024.
- Over the past year, FBIO quarterly retained earnings has dropped by -$48.51 million (-7.08%).
- FBIO quarterly retained earnings is now -1372.47% below its all-time high of -$49.85 million, reached on September 30, 2011.
Performance
FBIO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
FBIO Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.6% | -7.1% |
| 3 y3 years | -43.9% | -34.1% |
| 5 y5 years | -75.3% | -53.8% |
FBIO Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -26.9% | at low | -34.1% | at low |
| 5 y | 5-year | -59.3% | at low | -68.3% | at low |
| alltime | all time | -1128.3% | at low | -1372.5% | at low |
Fortress Biotech Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$734.10 M(+1.8%) |
| Jun 2024 | - | -$721.24 M(+1.5%) |
| Mar 2024 | - | -$710.29 M(+2.2%) |
| Dec 2023 | -$694.87 M(+9.6%) | -$694.87 M(+1.4%) |
| Sep 2023 | - | -$685.59 M(+0.7%) |
| Jun 2023 | - | -$680.55 M(+3.8%) |
| Mar 2023 | - | -$655.77 M(+3.4%) |
| Dec 2022 | -$634.23 M(+15.8%) | -$634.23 M(+4.5%) |
| Sep 2022 | - | -$607.09 M(+3.9%) |
| Jun 2022 | - | -$584.58 M(+3.8%) |
| Mar 2022 | - | -$563.22 M(+2.9%) |
| Dec 2021 | -$547.46 M(+13.4%) | -$547.46 M(+6.1%) |
| Sep 2021 | - | -$515.90 M(+4.2%) |
| Jun 2021 | - | -$495.12 M(+0.7%) |
| Mar 2021 | - | -$491.58 M(+1.8%) |
| Dec 2020 | -$482.76 M(+10.7%) | -$482.76 M(+1.1%) |
| Sep 2020 | - | -$477.46 M(+3.4%) |
| Jun 2020 | - | -$461.92 M(+3.0%) |
| Mar 2020 | - | -$448.60 M(+2.8%) |
| Dec 2019 | -$436.23 M(+10.1%) | -$436.23 M(+3.7%) |
| Sep 2019 | - | -$420.74 M(+3.1%) |
| Jun 2019 | - | -$407.98 M(+3.3%) |
| Mar 2019 | - | -$394.88 M(-0.4%) |
| Dec 2018 | -$396.27 M | -$396.27 M(+6.7%) |
| Sep 2018 | - | -$371.39 M(+4.7%) |
| Jun 2018 | - | -$354.76 M(+6.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | -$333.14 M(+6.7%) |
| Dec 2017 | -$312.13 M(+27.3%) | -$312.13 M(+3.5%) |
| Sep 2017 | - | -$301.71 M(+9.9%) |
| Jun 2017 | - | -$274.60 M(+6.8%) |
| Mar 2017 | - | -$257.23 M(+4.9%) |
| Dec 2016 | -$245.25 M(+29.0%) | -$245.25 M(+7.7%) |
| Sep 2016 | - | -$227.82 M(+6.0%) |
| Jun 2016 | - | -$214.84 M(+6.2%) |
| Mar 2016 | - | -$202.36 M(+6.4%) |
| Dec 2015 | -$190.16 M(+34.2%) | -$190.16 M(+6.8%) |
| Sep 2015 | - | -$178.12 M(+11.4%) |
| Jun 2015 | - | -$159.96 M(+4.0%) |
| Mar 2015 | - | -$153.78 M(+8.5%) |
| Dec 2014 | -$141.73 M(+16.8%) | -$141.73 M(+2.7%) |
| Sep 2014 | - | -$138.01 M(+3.4%) |
| Jun 2014 | - | -$133.42 M(+3.7%) |
| Mar 2014 | - | -$128.71 M(+6.1%) |
| Dec 2013 | -$121.34 M(+44.1%) | -$121.34 M(+8.8%) |
| Sep 2013 | - | -$111.54 M(+7.6%) |
| Jun 2013 | - | -$103.71 M(+11.5%) |
| Mar 2013 | - | -$93.04 M(+10.5%) |
| Dec 2012 | -$84.18 M(+48.8%) | -$84.18 M(+11.5%) |
| Sep 2012 | - | -$75.52 M(+8.5%) |
| Jun 2012 | - | -$69.58 M(+10.2%) |
| Mar 2012 | - | -$63.13 M(+11.6%) |
| Dec 2011 | -$56.57 M | -$56.57 M(+13.5%) |
| Sep 2011 | - | -$49.85 M |
FAQ
- What is Fortress Biotech annual retained earnings?
- What is the all time high annual retained earnings for Fortress Biotech?
- What is Fortress Biotech annual retained earnings year-on-year change?
- What is Fortress Biotech quarterly retained earnings?
- What is the all time high quarterly retained earnings for Fortress Biotech?
- What is Fortress Biotech quarterly retained earnings year-on-year change?
What is Fortress Biotech annual retained earnings?
The current annual retained earnings of FBIO is -$694.87 M
What is the all time high annual retained earnings for Fortress Biotech?
Fortress Biotech all-time high annual retained earnings is -$56.57 M
What is Fortress Biotech annual retained earnings year-on-year change?
Over the past year, FBIO annual retained earnings has changed by -$60.64 M (-9.56%)
What is Fortress Biotech quarterly retained earnings?
The current quarterly retained earnings of FBIO is -$734.10 M
What is the all time high quarterly retained earnings for Fortress Biotech?
Fortress Biotech all-time high quarterly retained earnings is -$49.85 M
What is Fortress Biotech quarterly retained earnings year-on-year change?
Over the past year, FBIO quarterly retained earnings has changed by -$48.51 M (-7.08%)